March 1 (Reuters) - Rhythm Biosciences Ltd (RHY) : SEEKS TRADING HALT PENDING ANNOUNCEMENT ON THERAPEUTIC GOOD ADMINISTRATION SUBMISSIONCanadian Dollar. Created with Sketch. Share @smokeyd I assume you are asking about this latest announcement? All they have announced is that they have found a business (Nutripath) that they can pay/leverage. You won't cos you are just trying to make yourself sound good. Wonder if they'll list on the. @josiejow37 You are still pushing poo up hill mate. There is a challenge for RHY to release an announcement with the sensitivity and specificity of all stages of Study 7 Surely, someone at RHY looks at the forums. . ASX - Day Trading. Today’s RHY share price, stock chart and announcements. ASX - Day TradingNotification of cessation of securities - RHY. Jan 6 (Reuters) - Rhythm Biosciences Ltd (RHY) : SHARE PLACEMENT OF A$6. Gathering by everyones comments, Borano has excelled once again. . ASX - By Stock. Totally agree that some sort of commercialisation Agreement, even an MOU at this stage, would be an extremely. RHY have a very good strategy moving forward with market entry - plus there is a substantial R&D refund on its way. Application for quotation of securities - RHY. ASX - Day Trading. 0 Great analysis. Created with Sketch. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024 RHY management need to get off their backsides and tell the market where the hell they are at with any partnerships. Advertise on HotCopper. View today’s RHY share price, options, bonds, hybrids and warrants. Target our investor community with our suite of Hotcopper Advertising. ASX - By Stock. 00%. Unless someone else picks it up, RHY is probably gone in its current form. Welcome to your Arts Directory. Of course you made over half a million dollars on RHY. HotCopper has news, discussion, prices and market data on RHYTHM BIOSCIENCES LIMITED. BS from posters/long term holders as well as peak price purchasers that got a feel of FOMO as well. A Corporate Spotlight has been made available by RHYTHM BIOSCIENCES LIMITED and can be found on the RHY (ASX) page. If RHY prove me wrong I will say goodbye forever on this forum. Under the LDT path, RHY will be required to validate its test in the nominated laboratory. ASX - Day Trading. ASX - By Stock. ASX - Day Trading. Forums. Created with Sketch. So yes they have validated the test for people who turned out not to have cancer. Area (s) Cartoonist. Charts. Last updated 15. Specifically, several matters referred to in the presentation remain under investigation and are subject to change or even elimination, depending on further research and investigation. May 12 (Reuters) - Rhythm Biosciences Ltd (RHY) : CONFIRMS FILING WITH AUSTRALIAN TGA FOR LISTING OF COLOSTAT ON AUSTRALIAN REGISTER OF THERAPEUTIC GOODS, page-2. Latest Posts. Hopefully reversal starts from here. 0¢. I'll take a guess though - imminent launch of a ground breaking CRC blood test with better than 99% detection rates, Name of test or company not provided. 5 Upvote. NSX - By Stock. RHY have the cheapest test for CRC - even cheaper than the Stool kit, which does not specifically detect CRC 2. Created with Sketch. Looks to me that RHY forgot that the UK (England, Scotland, Wales and Northern Ireland) were no longer part of the European Union. - Strategic partner agreement - this will fast track their entry into the market place. Forums. 47pm 05/10/2023 ? Join the HotCopper ASX Stock discussion forum for RHYTHM BIOSCIENCES LIMITED. Colostat is the most covenient (blood test) and easiest to integrate into existing pathology labs - unlike DNA which requires re-tooling. 0¢. ASX - General. 6 Upvote. ASX - By Stock. ASX - Day TradingNCSR Bill. Appendix 4C - quarterlyRHY 2023 AGM PresentationRHY adds Sonic Clinical Services to ColoSTAT Clinical Trial. 33. ASX - Day TradingRhythm Biosciences Limited is a medical diagnostics technology company. Specifically, several matters referred to in the presentation remain under investigation and are subject to change or even elimination, depending on further research and investigation. 5m shares. 12 month rating for the stock was $3.